Filtros de búsqueda

Lista de obras de Philip W. Kantoff

(18)F-FDG-PET/CT and (18)F-NaF-PET/CT in men with castrate-resistant prostate cancer

artículo científico publicado en 2014

14-Day continuous infusion of mitoxantrone in hormone-refractory metastatic adenocarcinoma of the prostate

scientific article published on 01 December 1993

6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trial

artículo científico publicado en 2004

A Clinical Evaluation of Enzalutamide in Metastatic Castration-Sensitive Prostate Cancer: Guiding Principles for Treatment Selection and Perspectives on Research

scientific article published on 29 December 2020

A Genetic Variation of SOD2 Does Not Determine Duration of Response to Androgen Deprivation Therapy for Prostate Cancer

artículo científico publicado en 2016

A Novel Mechanism Driving Poor-Prognosis Prostate Cancer: Overexpression of the DNA Repair Gene, Ribonucleotide Reductase Small Subunit M2 (RRM2)

scientific article published on 17 April 2019

A Phase II Trial of Abiraterone Combined with Dutasteride for Men with Metastatic Castration-Resistant Prostate Cancer

artículo científico publicado en 2016

A Phase II trial of flavopiridol (NSC #649890) in patients with previously untreated metastatic androgen-independent prostate cancer

artículo científico publicado en 2004

A Prospective Study of Aspirin Use and Prostate Cancer Risk by TMPRSS2:ERG Status

scientific article published on 14 August 2018

A Randomized Phase II Trial of Short-Course Androgen Deprivation Therapy With or Without Bevacizumab for Patients With Recurrent Prostate Cancer After Definitive Local Therapy

artículo científico publicado en 2016

A dose finding clinical trial of cabozantinib (XL184) administered in combination with abiraterone acetate in metastatic castration-resistant prostate cancer

scientific article published on 07 June 2018

A large prospective study of SEP15 genetic variation, interaction with plasma selenium levels, and prostate cancer risk and survival

artículo científico publicado en 2010

A phase 2 trial of abiraterone acetate without glucocorticoids for men with metastatic castration-resistant prostate cancer

artículo científico publicado en 2018

A phase I study of estramustine, weekly docetaxel, and carboplatin chemotherapy in patients with hormone-refractory prostate cancer.

artículo científico publicado en 2005

A phase I study of everolimus and docetaxel in patients with castration-resistant prostate cancer

artículo científico publicado en 2014

A phase I trial of a recombinant vaccinia virus expressing prostate-specific antigen in advanced prostate cancer.

artículo científico publicado en 2000

A phase II study of mifepristone (RU-486) in castration-resistant prostate cancer, with a correlative assessment of androgen-related hormones.

artículo científico publicado en 2008

A phase II trial of interferon-alpha and toremifene in advanced renal cell cancer patients

artículo científico publicado en 2002

A phase II trial of methotrexate, cisplatin, 5-fluorouracil, and leucovorin in the treatment of invasive and metastatic urothelial carcinoma

artículo científico publicado en 1999

A polymorphism of the 5 alpha-reductase gene and its association with prostate cancer: a case-control analysis

artículo científico publicado en 1997

A prognostic index model for predicting overall survival in patients with metastatic castration-resistant prostate cancer treated with abiraterone acetate after docetaxel.

artículo científico publicado en 2015

A prognostic score for hormone-refractory prostate cancer: analysis of two cancer and leukemia group B studies

artículo científico publicado en 1999

A single nucleotide polymorphism in inflammatory gene RNASEL predicts outcome after radiation therapy for localized prostate cancer

artículo científico publicado en 2013

A transient increase in eosinophils is associated with prolonged survival in men with metastatic castration-resistant prostate cancer who receive sipuleucel-T.

artículo científico publicado en 2014

A whole-blood RNA transcript-based prognostic model in men with castration-resistant prostate cancer: a prospective study

artículo científico publicado en 2012

ATAAA repeat upstream of glutathione S-transferase P1 and prostate cancer risk

artículo científico publicado en 2002

ATR inhibition controls aggressive prostate tumors deficient in Y-linked histone demethylase KDM5D.

artículo científico publicado en 2018

Abiraterone Acetate Induces CREB1 Phosphorylation and Enhances the Function of the CBP-p300 Complex, Leading to Resistance in Prostate Cancer Cells

artículo científico publicado en 2021

Abiraterone treatment in castration-resistant prostate cancer selects for progesterone responsive mutant androgen receptors

artículo científico publicado en 2014

Absence of a correlation of androgen receptor gene CAG repeat length and prostate cancer risk in an African-American population

artículo científico publicado en 2004

Activating mTOR mutations in a patient with an extraordinary response on a phase I trial of everolimus and pazopanib

artículo científico publicado en 2014

Active surveillance compared with initial treatment for men with low-risk prostate cancer: a decision analysis

artículo científico publicado en 2010

Active surveillance for early-stage prostate cancer: review of the current literature

artículo científico publicado en 2008

Activities and accomplishments of the cancer and leukemia group B genitourinary committee.

artículo científico publicado en 2006

Activity of dutasteride plus ketoconazole in castration-refractory prostate cancer after progression on ketoconazole alone

artículo científico publicado en 2009

Activity of ketoconazole after taxane-based chemotherapy in castration-resistant prostate cancer

artículo científico publicado en 2009

Activity of the herbal combination, PC-SPES, in the treatment of patients with androgen-independent prostate cancer

article

Acupuncture Versus Cognitive Behavioral Therapy for Insomnia in Cancer Survivors: A Randomized Clinical Trial

scientific article published on 01 December 2019

Adrenal androgen levels as predictors of outcome in prostate cancer patients treated with ketoconazole plus antiandrogen withdrawal: results from a cancer and leukemia group B study.

artículo científico publicado en 2007

Advances in the treatment of prostate cancer

artículo científico publicado en 2007

Adverse effects of androgen deprivation therapy and strategies to mitigate them.

artículo científico publicado en 2014

Amplified in Breast Cancer-1 Glutamine Repeat and Prostate Cancer Risk

Analysis of the 10q11 cancer risk locus implicates MSMB and NCOA4 in human prostate tumorigenesis

artículo científico publicado en 2010

Analysis of the Prevalence of Microsatellite Instability in Prostate Cancer and Response to Immune Checkpoint Blockade

scientific article published on 01 April 2019

Analysis of the correlation between endorectal MRI response to neoadjuvant chemotherapy and biochemical recurrence in patients with high-risk localized prostate cancer

artículo científico publicado en 2013

Androgen Deprivation Therapy Is Associated With Prolongation of QTc Interval in Men With Prostate Cancer.

artículo científico publicado en 2018

Androgen deprivation therapy reversibly increases endothelium-dependent vasodilation in men with prostate cancer

artículo científico publicado en 2015

Androgen receptor CAG repeat polymorphism and risk of TMPRSS2:ERG-positive prostate cancer

artículo científico publicado en 2014

Androgen receptor mediates the expression of UDP-glucuronosyltransferase 2 B15 and B17 genes

artículo científico publicado en 2008

Androgen receptor mutations in androgen-independent prostate cancer: Cancer and Leukemia Group B Study 9663.

artículo científico publicado en 2003

Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer

scientific article published on July 2009

Androgen receptor-mediated downregulation of microRNA-221 and -222 in castration-resistant prostate cancer.

artículo científico publicado en 2017

Androgen suppression and radiation vs radiation alone for prostate cancer: a randomized trial

artículo científico

Aneuploidy drives lethal progression in prostate cancer

scientific article published on 13 May 2019

Antiandrogens in prostate cancer

artículo científico publicado en 1999

Application of oligonucleotide microarrays to assess the biological effects of neoadjuvant imatinib mesylate treatment for localized prostate cancer

artículo científico publicado en 2006

Aspirin and hormone therapy for prostate cancer

artículo científico publicado en 2007

Assessment of prostate cancer volume using endorectal coil magnetic resonance imaging: a new predictor of tumor response to neoadjuvant androgen suppression therapy

artículo científico publicado en 1998

Association between the Met326Ile polymorphism of the p85alpha regulatory subunit of phosphatidylinositol 3-kinase and prostate cancer risk: a prospective study.

artículo científico publicado en 2003

Association of AR-V7 and Prostate-Specific Antigen RNA Levels in Blood with Efficacy of Abiraterone Acetate and Enzalutamide Treatment in Men with Prostate Cancer

artículo científico publicado en 2016

Association of HSD3B1 Genotype With Response to Androgen-Deprivation Therapy for Biochemical Recurrence After Radiotherapy for Localized Prostate Cancer

artículo científico publicado en 2017

Association of SLCO2B1 Genotypes With Time to Progression and Overall Survival in Patients Receiving Androgen-Deprivation Therapy for Prostate Cancer

artículo científico publicado en 2015

Association of Tissue Abiraterone Levels and SLCO Genotype with Intraprostatic Steroids and Pathologic Response in Men with High-Risk Localized Prostate Cancer.

artículo científico publicado en 2017

Association of genetic variation of the six gene prognostic model for castration-resistant prostate cancer with survival

artículo científico publicado en 2018

Association of genetic variations of selenoprotein genes, plasma selenium levels, and prostate cancer aggressiveness at diagnosis

artículo científico publicado en 2016

Association of prostate cancer risk Loci with disease aggressiveness and prostate cancer-specific mortality

artículo científico publicado en 2011

Associations of prostate cancer risk variants with disease aggressiveness: results of the NCI-SPORE Genetics Working Group analysis of 18,343 cases

artículo científico publicado en 2015

Attempts at gene therapy in beta-thalassemic mice

artículo científico publicado en 1985

Attenuation of SRC kinase activity augments PARP inhibitor-mediated synthetic lethality in BRCA2-altered prostate tumors

artículo científico publicado en 2020

Author Correction: Restoration of tumour-growth suppression in vivo via systemic nanoparticle-mediated delivery of PTEN mRNA

artículo científico publicado en 2018

Autoantibody signatures in prostate cancer

artículo científico publicado en 2005

BRAF mutations in metanephric adenoma of the kidney

artículo científico publicado en 2012

Benchmarks for Academic Oncology Faculty

scientific article published on 30 September 2020

Biochemical outcome following external beam radiation therapy with or without androgen suppression therapy for clinically localized prostate cancer

scientific article published on 01 September 2000

Biopsy Gleason score and the duration of testosterone suppression among men treated with external beam radiation and 6 months of combined androgen blockade.

artículo científico publicado en 2012

Bladder cancer

artículo científico publicado en 1990

Bone directed therapies for prostate cancer

artículo científico publicado en 2007

CAG repeat within the androgen receptor gene and incidence of surgery for benign prostatic hyperplasia in U.S. physicians

scientific article published on 01 May 1999

CML28 is a broadly immunogenic antigen, which is overexpressed in tumor cells.

artículo científico publicado en 2002

CML66, a broadly immunogenic tumor antigen, elicits a humoral immune response associated with remission of chronic myelogenous leukemia

artículo científico publicado en 2001

CT and pathologic predictive features of residual mass histologic findings after chemotherapy for nonseminomatous germ cell tumors: can residual malignancy or teratoma be excluded? ⬇️

artículo científico publicado el 1 de septiembre de 1991

Cabozantinib Inhibits Abiraterone's Upregulation of IGFIR Phosphorylation and Enhances Its Anti-Prostate Cancer Activity.

artículo científico publicado en 2015

Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma

artículo científico publicado en 2015

Cancer and Leukemia Group B trials for advanced prostate cancer.

artículo científico publicado en 1996

Cancer nanomedicine: progress, challenges and opportunities

artículo científico publicado en 2016

Carboplatin for Stage I Seminoma

article

Case 1-2000

artículo científico publicado en 2000

Castration Resistance in Prostate Cancer Is Mediated by the Kinase NEK6.

artículo científico publicado en 2016

Causes of death in men undergoing androgen suppression therapy for newly diagnosed localized or recurrent prostate cancer

artículo científico publicado en 2008

Celecoxib versus placebo for men with prostate cancer and a rising serum prostate-specific antigen after radical prostatectomy and/or radiation therapy

artículo científico publicado en 2006

Changes In PSA Kinetics After DNA Vaccine Therapy–Not So Fast!

artículo científico publicado en 2009

Changes in body composition during androgen deprivation therapy for prostate cancer

artículo científico publicado en 2002

ChemoRad nanoparticles: a novel multifunctional nanoparticle platform for targeted delivery of concurrent chemoradiation.

artículo científico publicado en 2010

Chemotherapy for metastatic bladder cancer

artículo científico publicado en 1992

Chemotherapy for muscle-infiltrating bladder cancer

artículo científico publicado el 1 de febrero de 1992

Chemotherapy for prostate cancer.

artículo científico publicado en 2002

Chemotherapy for teratoma with malignant transformation

artículo científico publicado en 2003

Clinical Outcomes of First-line Abiraterone Acetate or Enzalutamide for Metastatic Castration-resistant Prostate Cancer After Androgen Deprivation Therapy + Docetaxel or ADT Alone for Metastatic Hormone-sensitive Prostate Cancer

artículo científico publicado en 2017

Clinical Progression to Castration-Recurrent Prostate Cancer

Clinical annotations for prostate cancer research: Defining data elements, creating a reproducible analytical pipeline, and assessing data quality

artículo científico publicado en 2022

Clinical implementation of integrated whole-genome copy number and mutation profiling for glioblastoma

artículo científico publicado en 2015

Clinical predictors of survival in men with castration-resistant prostate cancer: evidence that Gleason score 6 cancer can evolve to lethal disease

artículo científico publicado en 2013

Clinical roundtable monograph: new and emerging treatments for advanced prostate cancer

artículo científico publicado el 1 de junio de 2011

Comorbidity, body mass index, and age and the risk of nonprostate-cancer-specific mortality after a postradiation prostate-specific antigen recurrence

scientific article published on 01 February 2010

Comparing prostate specific antigen outcomes after different types of radiotherapy management of clinically localized prostate cancer highlights the importance of controlling for established prognostic factors

artículo científico publicado en 2000

Comparison of Prostate-Specific Membrane Antigen-Based 18F-DCFBC PET/CT to Conventional Imaging Modalities for Detection of Hormone-Naïve and Castration-Resistant Metastatic Prostate Cancer

artículo científico publicado en 2015

Complications after treatment with external-beam irradiation in early-stage prostate cancer patients: a prospective multiinstitutional outcomes study

artículo científico publicado en 1997

Constitutive expression of high levels of prostate-specific antigen in the absence of prostate carcinoma

artículo científico publicado en 1996

Contemporary nationwide patterns of self-reported prostate-specific antigen screening

artículo científico publicado en 2014

Contemporary trends in low risk prostate cancer: risk assessment and treatment

artículo científico publicado en 2007

Cooperative group tissue banks as research resources: the cancer and leukemia group B tissue repositories

scientific article published on 01 May 2002

Correction of adenosine deaminase deficiency in cultured human T and B cells by retrovirus-mediated gene transfer

artículo científico publicado en 1986

Current treatment strategies for advanced prostate cancer

artículo científico publicado en 2017

DNA copy number analysis of metastatic urothelial carcinoma with comparison to primary tumors

artículo científico publicado en 2015

Debrisoquine hydroxylase (CYP2D6) and prostate cancer

artículo científico publicado en 1998

Decreased alpha-methylacyl CoA racemase expression in localized prostate cancer is associated with an increased rate of biochemical recurrence and cancer-specific death

artículo científico publicado en 2005

Defining the optimal approach to the patient with postradiation prostate-specific antigen recurrence using outcome data from a prospective randomized trial

artículo científico publicado en 2013

Demystifying immunotherapy in prostate cancer: understanding current and future treatment strategies.

artículo científico publicado en 2013

Department of Defense prostate cancer clinical trials consortium: a new instrument for prostate cancer clinical research.

artículo científico publicado en 2009

Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group

artículo científico publicado en 2008

Detection of circulating tumor cells in men with localized prostate cancer

artículo científico publicado en 1994

Development and clinical validation of an in situ biopsy-based multimarker assay for risk stratification in prostate cancer

artículo científico publicado en 2015

Development of an integrated prostate cancer research information system.

artículo científico publicado en 2006

Development of multinuclear polymeric nanoparticles as robust protein nanocarriers

artículo científico publicado en 2014

Differentiating agents and the treatment of prostate cancer: Vitamin D3 and peroxisome proliferator-activated receptor gamma ligands

artículo científico publicado en 2003

Diversity of Enrollment in Prostate Cancer Clinical Trials: Current Status and Future Directions

artículo científico publicado en 2020

Docetaxel (Taxotere)-based chemotherapy for hormone-refractory and locally advanced prostate cancer.

artículo científico publicado en 1999

Docetaxel, bevacizumab, and androgen deprivation therapy for biochemical disease recurrence after definitive local therapy for prostate cancer

artículo científico publicado en 2015

Does androgen deprivation therapy in men with prostate cancer increase cardiovascular morbidity?

artículo científico publicado en 2007

Double-blind, randomized trial of docetaxel plus vandetanib versus docetaxel plus placebo in platinum-pretreated metastatic urothelial cancer

artículo científico publicado en 2011

Dual Blockade of c-MET and the Androgen Receptor in Metastatic Castration-Resistant Prostate Cancer: A Phase 1 Study of Concurrent Enzalutamide and Crizotinib

scientific article published on 17 September 2020

Duration of Androgen Deprivation Therapy for High-Risk Prostate Cancer: Application of Randomized Trial Data in a Tertiary Referral Cancer Center

artículo científico publicado en 2015

Duration of Short-Course Androgen Suppression Therapy and the Risk of Death As a Result of Prostate Cancer

article

Duration of the anti-androgen in men undergoing 6 months of an LHRH agonist and radiation therapy for unfavorable-risk prostate cancer and the risk of death

scientific article published on 08 November 2016

EZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independent

artículo científico publicado en 2012

Early Versus Delayed Initiation of Salvage Androgen Deprivation Therapy and Risk of Prostate Cancer-Specific Mortality

artículo científico publicado en 2018

Early detection of prostate cancer: AUA Guideline

artículo científico publicado en 2013

Effect of finasteride on risk of prostate cancer: how little we really know.

artículo científico publicado en 2004

Effect of internal viral sequences on the utility of retroviral vectors

artículo científico publicado en 1987

Effects of Androgen Deprivation Therapy on Pain Perception, Quality of Life, and Depression in Men With Prostate Cancer

artículo científico publicado en 2017

Effects of G/A polymorphism, rs266882, in the androgen response element 1 of the PSA gene on prostate cancer risk, survival and circulating PSA levels

artículo científico publicado en 2008

Effects of a gift certificate incentive and specialized delivery on prostate cancer survivors' response rate to a mailed survey: a randomized-controlled trial

artículo científico publicado en 2013

Effects of acupuncture versus cognitive behavioral therapy on cognitive function in cancer survivors with insomnia: A secondary analysis of a randomized clinical trial

artículo científico publicado en 2020

Effects of ligand activation of peroxisome proliferator-activated receptor gamma in human prostate cancer

artículo científico publicado en 2000

Efficacy of androgen deprivation therapy (ADT) in patients with advanced prostate cancer

article

Efficacy of nilutamide as secondary hormonal therapy in androgen-independent prostate cancer

artículo científico publicado en 2005

Elevated IL-8, TNF-α, and MCP-1 in men with metastatic prostate cancer starting androgen-deprivation therapy (ADT) are associated with shorter time to castration-resistance and overall survival

artículo científico publicado en 2014

Elevated insulin-like growth factor binding protein-1 (IGFBP-1) in men with metastatic prostate cancer starting androgen deprivation therapy (ADT) is associated with shorter time to castration resistance and overall survival

artículo científico publicado en 2013

Elevated plasma tissue inhibitor of metalloproteinase-1 levels predict decreased survival in castration-resistant prostate cancer patients

artículo científico publicado en 2010

Eleventh Prouts Neck Meeting on Prostate Cancer: Emerging Strategies in Prostate Cancer Therapy

artículo científico publicado en 2007

Eligibility and outcomes reporting guidelines for clinical trials for patients in the state of a rising prostate-specific antigen: recommendations from the Prostate-Specific Antigen Working Group

artículo científico publicado en 2004

Emerging players in prostate cancer: long non-coding RNAs

artículo científico publicado en 2014

Enhancer RNAs participate in androgen receptor-driven looping that selectively enhances gene activation

artículo científico publicado en 2014

Enhancing tumor cell response to chemotherapy through nanoparticle-mediated codelivery of siRNA and cisplatin prodrug.

artículo científico publicado en 2013

Erratum: TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort

article

Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer

artículo científico publicado en 2008

Evaluating the combined effect of comorbidity and prostate-specific antigen kinetics on the risk of death in men after prostate-specific antigen recurrence

artículo científico publicado en 2009

Evaluation of 8q24 and 17q risk loci and prostate cancer mortality

artículo científico publicado en 2009

Evaluation of the 8q24 prostate cancer risk locus and MYC expression.

artículo científico publicado en 2009

Event-Free Survival, a Prostate-Specific Antigen-Based Composite End Point, Is Not a Surrogate for Overall Survival in Men With Localized Prostate Cancer Treated With Radiation

scientific article published on 18 June 2020

Evidence that the CAG repeat in the androgen receptor gene is associated with the age-related decline in serum androgen levels in men

article

Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer

artículo científico publicado en 2012

Expression Levels of DNA Damage Repair Proteins Are Associated With Overall Survival in Platinum-Treated Advanced Urothelial Carcinoma

artículo científico publicado en 2015

Expression differences of circulating microRNAs in metastatic castration resistant prostate cancer and low-risk, localized prostate cancer

artículo científico

Expression of a human complementary DNA for the multidrug resistance gene in murine hematopoietic precursor cells with the use of retroviral gene transfer

artículo científico publicado en 1990

Expression of human adenosine deaminase in nonhuman primates after retrovirus-mediated gene transfer

artículo científico publicado en 1987

Expression of lncRNA MIR222HG co-transcribed from the miR-221/222 gene promoter facilitates the development of castration-resistant prostate cancer

artículo científico publicado en 2018

FGFR3 expression in primary and metastatic urothelial carcinoma of the bladder

artículo científico publicado en 2014

Family history of prostate cancer and the incidence of ERG- and phosphatase and tensin homolog-defined prostate cancer

scientific article published on 27 July 2019

Feasibility of radical prostatectomy after neoadjuvant chemohormonal therapy for patients with high risk or locally advanced prostate cancer: results of a phase I/II study

artículo científico publicado en 2004

Finasteride and bicalutamide as primary hormonal therapy in patients with advanced adenocarcinoma of the prostate

artículo científico publicado en 2004

Finasteride and flutamide as potency-sparing androgen-ablative therapy for advanced adenocarcinoma of the prostate

artículo científico publicado en 1997

Finasteride and flutamide therapy in patients with advanced prostate cancer: response to subsequent castration and long-term follow-up

artículo científico publicado en 2003

Fourth International Conference on Innovations and Challenges in Prostate Cancer: Prevention, Detection and Treatment

artículo científico publicado en 2004

Functional analysis of single cells identifies a rare subset of circulating tumor cells with malignant traits

artículo científico publicado en 2014

Functional enhancers at the gene-poor 8q24 cancer-linked locus.

artículo científico publicado en 2009

Gallium-67-citrate imaging in extragonadal and gonadal seminomas: relationship to radiologic findings

artículo científico publicado en 1994

Gene expression correlates of clinical prostate cancer behavior

article

Gene expression in mice after high efficiency retroviral-mediated gene transfer

scientific article published on 01 December 1985

Gene expression profiling of prostate tissue identifies chromatin regulation as a potential link between obesity and lethal prostate cancer

artículo científico

Gene therapy: efforts at developing large animal models for autologous bone marrow transplant and gene transfer with retroviral vectors

artículo científico publicado en 1987

Gene transfer and expression in nonhuman primates using retroviral vectors

artículo científico publicado en 1986

Gene transfer into animals by retroviral vectors

artículo científico publicado en 1986

Gene transfer into hematopoietic progenitor cells from normal and cyclic hematopoietic dogs using retroviral vectors

artículo científico publicado en 1988

Genetic and functional analyses implicate the NUDT11, HNF1B, and SLC22A3 genes in prostate cancer pathogenesis

artículo científico publicado en 2012

Genetic determinants of prostate cancer risk

artículo científico publicado en 2007

Genitourinary malignancies.

artículo científico publicado en 1999

Genome-wide association study of prostate cancer mortality

artículo científico publicado en 2010

Genome-wide loss of heterozygosity analysis from laser capture microdissected prostate cancer using single nucleotide polymorphic allele (SNP) arrays and a novel bioinformatics platform dChipSNP.

artículo científico publicado en 2003

Genomic Evaluation and Management of Prostate Cancer

Genomic correlates of clinical outcome in advanced prostate cancer.

artículo científico publicado en 2019

Genotyping and functional analysis of the D104N variant of human endostatin

article

GermLine Variation in Superoxide Dismutase-2 (SOD2) and Survival Outcomes After Radiation Therapy for Prostate Cancer: Results of a Test and Validation Set Analysis

artículo científico publicado en 2015

Germline CAG repeat length of the androgen receptor and time to progression in patients with prostate cancer treated with androgen deprivation therapy.

artículo científico publicado en 2011

HRAS1 Proto-Oncogene Polymorphism and Prostate Cancer

Her-2-neu expression and progression toward androgen independence in human prostate cancer

artículo científico publicado en 2000

High-fat diet fuels prostate cancer progression by rewiring the metabolome and amplifying the MYC program

scientific article published on 25 September 2019

High-level recombinant gene expression in rabbit endothelial cells transduced by retroviral vectors

artículo científico publicado en 1989

Histologic Demonstration of Intradermal Spirochetes in a Patient with Lyme Disease

scientific article published on 01 March 1984

Hormonal perturbations in patients with testicular cancer treated with cisplatin

artículo científico publicado en 1992

Hormone-refractory prostate cancer: choosing the appropriate treatment option.

artículo científico publicado en 2007

Humoral Immune Response against Nontargeted Tumor Antigens after Treatment with Sipuleucel-T and Its Association with Improved Clinical Outcome

artículo científico publicado en 2015

Hydrocortisone with or without mitoxantrone in men with hormone-refractory prostate cancer: results of the cancer and leukemia group B 9182 study

artículo científico publicado en 1999

Identification of ALK gene alterations in urothelial carcinoma

artículo científico publicado en 2014

Identifying suicidal symptoms in prostate cancer survivors using brief self-report

artículo científico publicado en 2014

Imaging yield from 133 consecutive patients with prostate cancer and low trigger PSA from a single institution.

artículo científico publicado en 2016

Imaging, procedural and clinical variables associated with tumor yield on bone biopsy in metastatic castration-resistant prostate cancer

artículo científico publicado en 2014

Immunohistochemical expression of BRCA1 and lethal prostate cancer

artículo científico publicado en 2010

Immunotherapy for castration-resistant prostate cancer

artículo científico publicado en 2012

Immunotherapy for the treatment of prostate cancer

artículo científico publicado en 2011

Impact of 5α-reductase inhibitor and α-blocker therapy for benign prostatic hyperplasia on prostate cancer incidence and mortality

artículo científico publicado en 2018

Impact of new systemic therapies on overall survival of patients with metastatic castration-resistant prostate cancer in a hospital-based registry

artículo científico publicado en 2019

Impact of symptomatic skeletal events on health-care resource utilization and quality of life among patients with castration-resistant prostate cancer and bone metastases

artículo científico publicado en 2017

Impact of time to testosterone rebound and comorbidity on the risk of cause-specific mortality in men with unfavorable-risk prostate cancer.

artículo científico publicado en 2018

Importance of serum hemoglobin in hormone refractory prostate cancer

scientific article published on 01 April 2002

In Reply

In Reply

article published in 2008

In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs

scientific article published on 23 July 2015

In utero gene transfer and expression: a sheep transplantation model.

artículo científico publicado en 1989

Inferences about drug safety in phase 3 trials in oncology: Examples from advanced prostate cancer

artículo científico publicado en 2020

Influence of Androgen Deprivation Therapy on All-Cause Mortality in Men With High-Risk Prostate Cancer and a History of Congestive Heart Failure or Myocardial Infarction

artículo científico publicado en 2011

Influence of Androgen Suppression Therapy for Prostate Cancer on the Frequency and Timing of Fatal Myocardial Infarctions

scientific article published on 01 June 2007

Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer

scientific article published on 06 July 2016

Inherited variants in the chemokine CCL2 gene and prostate cancer aggressiveness in a Caucasian cohort

artículo científico publicado en 2010

Inherited variation in the androgen pathway is associated with the efficacy of androgen-deprivation therapy in men with prostate cancer

artículo científico publicado en 2008

Inherited variations in AR, ESR1, and ESR2 genes are not associated with prostate cancer aggressiveness or with efficacy of androgen deprivation therapy

artículo científico publicado en 2010

Inhibition of EZH2 transactivation function sensitizes solid tumors to genotoxic stress

artículo científico publicado en 2022

Initial decline in hemoglobin during neoadjuvant hormonal therapy predicts for early prostate specific antigen failure following radiation and hormonal therapy for patients with intermediate and high-risk prostate cancer

artículo científico publicado en 2002

Innovations and Challenges in Prostate Cancer: Summary Statement for the 6th Cambridge Conference

article

Institutional implementation of clinical tumor profiling on an unselected cancer population

artículo científico publicado en 2016

Integration of immunotherapy into the management of advanced prostate cancer ⬇️

artículo científico publicado el 1 de septiembre de 2012

Integrative Clinical Genomics of Advanced Prostate Cancer

artículo científico publicado en 2015

Integrative analyses reveal a long noncoding RNA-mediated sponge regulatory network in prostate cancer

artículo científico publicado en 2016

Integrative analysis of 1q23.3 copy-number gain in metastatic urothelial carcinoma.

artículo científico publicado en 2014

Integrative clinical genomics of advanced prostate cancer

artículo científico publicado en 2015

Intense androgen-deprivation therapy with abiraterone acetate plus leuprolide acetate in patients with localized high-risk prostate cancer: results of a randomized phase II neoadjuvant study

artículo científico publicado en 2014

Interval to testosterone recovery after hormonal therapy for prostate cancer and risk of death.

artículo científico publicado en 2009

Intratumoral Sterol-27-Hydroxylase (CYP27A1) Expression in Relation to Cholesterol Synthesis and Vitamin D Signaling and Its Association with Lethal Prostate Cancer

artículo científico publicado en 2019

Intravesical therapy for superficial bladder cancer: is it a wash?

scientific article published on 01 January 1994

Is adjuvant chemotherapy necessary for patients with stage B1 testicular cancer?

artículo científico publicado en 1991

Is the Evidence Sufficient to Recommend Statins for All Men With Prostate Cancer?

artículo científico publicado en 2017

Kidney cancer. Clinical practice guidelines in oncology

artículo científico publicado en 2006

Kidney cancer. Clinical practice guidelines.

artículo científico publicado en 2005

Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell testicular cancer: a long-term update.

artículo científico publicado en 2003

Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell testicular tumors

artículo científico publicado en 1999

Laparoscopic retroperitoneal lymphadenectomy: multi-institutional analysis

artículo científico publicado en 1994

Late toxicities, long-term follow-up, less intensive treatment: leading issues in the therapy of testis cancer

artículo científico publicado en 1988

Long-term Follow-up of a Phase II Trial of Chemotherapy Plus Hormone Therapy for Biochemical Relapse After Definitive Local Therapy for Prostate Cancer

artículo científico publicado en 2013

Long-term Follow-up of a Randomized Trial of Radiation With or Without Androgen Deprivation Therapy for Localized Prostate Cancer

artículo científico publicado en 2015

Long-term followup of 150 patients with testicular cancer treated at a single institution

artículo científico publicado el 1 de enero de 1992

Low Expression of the Androgen-Induced Tumor Suppressor Gene PLZF and Lethal Prostate Cancer

artículo científico publicado en 2019

Low bone mineral density in hormone-naïve men with prostate carcinoma

artículo científico publicado en 2001

Low rate of clinician-scored gynecomastia induced by 6 months of combined androgen blockade in a randomized trial: Implications for prophylactic breast irradiation

artículo científico publicado en 2011

Low testosterone at first prostate-specific antigen failure and assessment of risk of death in men with unfavorable-risk prostate cancer treated on prospective clinical trials.

artículo científico publicado en 2017

Lower baseline prostate-specific antigen is associated with a greater overall survival benefit from sipuleucel-T in the Immunotherapy for Prostate Adenocarcinoma Treatment (IMPACT) trial

artículo científico publicado en 2013

MANAGEMENT OF HORMONE REFRACTORY PROSTATE CANCER: CURRENT STANDARDS AND FUTURE PROSPECTS

scholarly article by WILLIAM K. OH & Philip W. Kantoff published October 1998 in Journal of Urology

Male patients with diagnoses of both breast cancer and prostate cancer

artículo científico publicado en 2003

Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019

artículo científico publicado en 2020

Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017.

artículo científico publicado en 2017

Management of hormone refractory prostate cancer: current standards and future prospects ⬇️

artículo científico publicado el 1 de octubre de 1998

Manganese superoxide dismutase polymorphism, prediagnostic antioxidant status, and risk of clinical significant prostate cancer

artículo científico publicado en 2005

Measurement of plasma levels of vascular endothelial growth factor in prostate cancer patients: relationship with clinical stage, Gleason score, prostate volume, and serum prostate-specific antigen

artículo científico publicado en 2006

Measuring PI3K Activation: Clinicopathologic, Immunohistochemical, and RNA Expression Analysis in Prostate Cancer

artículo científico publicado en 2015

Mechanisms Responsible for Reduced Erythropoiesis during Androgen Deprivation Therapy in Men with Prostate Cancer

artículo científico publicado en 2018

Medical Management of Prostate Cancer

Meningeal carcinomatosis from transitional cell carcinoma of the bladder

artículo científico publicado en 1993

Metastasis-Free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate Cancer

artículo científico

Metastatic prostate carcinoma

artículo científico publicado el 20 de septiembre de 2001

Methylation-associated miR-193b silencing activates master drivers of aggressive prostate cancer ⬇️

artículo científico publicado en 2019

MiR-221 promotes the development of androgen independence in prostate cancer cells via downregulation of HECTD2 and RAB1A.

artículo científico publicado en 2013

Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive history.

artículo científico publicado en 2001

Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat

artículo científico publicado en 1999

Modification of the association between obesity and lethal prostate cancer by TMPRSS2:ERG

artículo científico publicado en 2013

Molecular sampling of prostate cancer: a dilemma for predicting disease progression

artículo científico publicado en 2010

Mortality and Hospitalization Risk Following Oral Androgen Signaling Inhibitors Among Men with Advanced Prostate Cancer by Pre-existing Cardiovascular Comorbidities

scientific article published on 13 August 2019

Multicenter phase II study of trabectedin in patients with metastatic castration-resistant prostate cancer

scientific article published on 19 September 2011

Multiplex immunofluorescence in formalin-fixed paraffin-embedded tumor tissue to identify single cell-level PI3K pathway activation

artículo científico publicado en 2020

Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing.

artículo científico publicado en 2017

Mutations in ribonuclease L gene do not occur at a greater frequency in patients with familial prostate cancer compared with patients with sporadic prostate cancer.

artículo científico publicado en 2003

NCCN Practice Guidelines for Prostate Cancer.

artículo científico publicado en 2000

NCCN Prostate Cancer Practice Guidelines. The National Comprehensive Cancer Network

scientific article published on 01 November 1996

NCCN clinical practice guidelines in oncology: prostate cancer

artículo científico publicado en 2010

Naming disease states for clinical utility in prostate cancer: a rose by any other name might not smell as sweet

artículo científico publicado en 2017

Natural history of untreated prostate specific antigen radiorecurrent prostate cancer in men with favorable prognostic indicators

artículo científico

Neoadjuvant Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin With Pegfilgrastim Support in Muscle-Invasive Urothelial Cancer: Pathologic, Radiologic, and Biomarker Correlates

scientific article published on 12 May 2014

Neoadjuvant Enzalutamide Prior to Prostatectomy

artículo científico publicado en 2016

Neoadjuvant and adjuvant chemotherapy for invasive bladder cancer.

artículo científico publicado en 1995

Neoadjuvant docetaxel before radical prostatectomy in patients with high-risk localized prostate cancer

artículo científico publicado en 2005

Neoadjuvant docetaxel followed by radical prostatectomy in patients with high-risk localized prostate cancer: a preliminary report

artículo científico publicado en 2001

Neoadjuvant doxil chemotherapy prior to androgen ablation plus radiotherapy for high-risk localized prostate cancer: feasibility and toxicity

artículo científico publicado en 2003

Neuroepithelial Tumor Arising in a Testicular Teratoma With Retroperitoneal Metastasis

artículo científico publicado en 2012

New agents in metastatic prostate cancer

artículo científico publicado en 2012

New agents in the therapy of hormone-refractory patients with prostate cancer.

artículo científico publicado en 1995

New and emerging treatments for advanced prostate cancer

artículo científico publicado el 1 de junio de 2011

New developments in the management of prostate cancer

artículo científico publicado en 2013

Nine-gene molecular signature is not associated with prostate cancer death in a watchful waiting cohort

artículo científico publicado en 2008

No association between a polymorphic variant of the IRS-1 gene and prostate cancer risk

artículo científico publicado en 2008

No association between the I105V polymorphism of the glutathione S-transferase P1 gene (GSTP1) and prostate cancer risk: a prospective study

artículo científico publicado en 2000

Noise and bias in microarray analysis of tumor specimens

artículo científico publicado en 2006

Nonpalpable Intratesticular Masses Detected Sonographically

scientific article published on 01 October 1995

Novel RB1-Loss Transcriptomic Signature Is Associated with Poor Clinical Outcomes across Cancer Types

scientific article published on 22 April 2019

Obesity and the Odds of Weight Gain following Androgen Deprivation Therapy for Prostate Cancer

artículo científico publicado en 2014

Observation versus initial treatment for men with localized, low-risk prostate cancer: a cost-effectiveness analysis

artículo científico publicado en 2013

Oncogenic genomic alterations, clinical phenotypes, and outcomes in metastatic castration-sensitive prostate cancer

scientific article published on 27 March 2020

Optimal timing of sipuleucel-T treatment in metastatic castration-resistant prostate cancer

artículo científico

Other novel agents: Rationale and current status as chemopreventive agents

artículo científico publicado en 2001

Overall survival analysis of a phase II randomized controlled trial of a Poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer

artículo científico publicado en 2010

Overexpression of the Long Non-coding RNA SChLAP1 Independently Predicts Lethal Prostate Cancer

artículo científico publicado en 2015

Overview consensus statement. Newer approaches to androgen deprivation therapy in prostate cancer

artículo científico publicado en 2002

PLZF, a tumor suppressor genetically lost in metastatic castration-resistant prostate cancer, is a mediator of resistance to androgen deprivation therapy

artículo científico publicado en 2015

PROSTATE-SPECIFIC ANTIGEN SCREENING FOR PROSTATE CANCER: A DECISION-ANALYTICAL PERSPECTIVE

artículo científico publicado en 2007

PTEN polymorphism (IVS4) is not associated with risk of prostate cancer

scientific article published on 01 April 2001

Paclitaxel, estramustine phosphate, and carboplatin in patients with advanced prostate cancer

artículo científico publicado en 2001

Pain predicts overall survival in men with metastatic castration-refractory prostate cancer.

artículo científico publicado en 2008

Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer

artículo científico publicado en 2001

Pan-cancer Analysis of CDK12 Alterations Identifies a Subset of Prostate Cancers with Distinct Genomic and Clinical Characteristics

artículo científico publicado en 2020

Patient-Reported Impotence and Incontinence After Nerve-Sparing Radical Prostatectomy

artículo científico publicado en 1997

Patient-reported symptoms after primary therapy for early prostate cancer: results of a prospective cohort study ⬇️

artículo científico publicado el 1 de enero de 1998

Patients with Biopsy Gleason 9 and 10 Prostate Cancer Have Significantly Worse Outcomes Compared to Patients with Gleason 8 Disease

artículo científico publicado en 2015

Patterns of self-reported care in a cohort of prostate cancer survivors: Implications for risk-stratified care

artículo científico publicado en 2020

Peroxisome proliferator-activated receptor gamma (PPargamma) as a novel target for prostate cancer

artículo científico publicado en 2002

Phase 1 study of PSMA ADC, an antibody-drug conjugate targeting prostate-specific membrane antigen, in chemotherapy-refractory prostate cancer

artículo científico publicado en 2019

Phase 2 study of neoadjuvant docetaxel plus bevacizumab in patients with high-risk localized prostate cancer: a Prostate Cancer Clinical Trials Consortium trial

artículo científico publicado en 2012

Phase I clinical trial of the CYP17 inhibitor abiraterone acetate demonstrating clinical activity in patients with castration-resistant prostate cancer who received prior ketoconazole therapy.

artículo científico publicado en 2010

Phase I/II study of vaccination with electrofused allogeneic dendritic cells/autologous tumor-derived cells in patients with stage IV renal cell carcinoma

artículo científico publicado en 2007

Phase II Study of Low Dose and High Dose Conjugated Estrogen for Androgen Independent Prostate Cancer

article

Phase II study of androgen synthesis inhibition with ketoconazole, hydrocortisone, and dutasteride in asymptomatic castration-resistant prostate cancer

artículo científico publicado en 2009

Phase II study of sunitinib in men with advanced prostate cancer.

artículo científico publicado en 2009

Phase II trial of RAD001 and bicalutamide for castration-resistant prostate cancer

artículo científico publicado en 2012

Phase III Trial of PROSTVAC in Asymptomatic or Minimally Symptomatic Metastatic Castration-Resistant Prostate Cancer

artículo científico publicado en 2019

Physical and emotional health information needs and preferences of long-term prostate cancer survivors

artículo científico publicado en 2016

Physician attitudes toward cytotoxic chemotherapy use in patients with advanced prostate carcinoma

artículo científico publicado en 2003

Plasma levels of heat shock protein 70 in patients with prostate cancer: a potential biomarker for prostate cancer

artículo científico publicado en 2004

Plasma levels of vascular endothelial growth factor are increased in patients with metastatic prostate cancer

scientific article published on 01 September 1999

Plasma selenium, manganese superoxide dismutase, and intermediate- or high-risk prostate cancer

artículo científico publicado en 2009

Platinum-Based Chemotherapy in Metastatic Prostate Cancer With DNA Repair Gene Alterations

artículo científico publicado en 2020

Polycomb-independent activity of EZH2 in castration resistant prostate cancer

Polymorphism in endostatin, an angiogenesis inhibitor, and prostate cancer risk and survival: A prospective study

artículo científico publicado en 2009

Population-based patterns of prescription androgen use, 1976-2008.

artículo científico publicado en 2014

Post prostatectomy outcomes of patients with high-risk prostate cancer treated with neoadjuvant androgen blockade

artículo científico publicado en 2017

Posttreatment Prostate Specific Antigen Nadir Predicts Prostate Cancer Specific and All Cause Mortality

artículo científico publicado en 2012

Potential applications of gene therapy

artículo científico publicado en 1989

Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile.

artículo científico publicado en 2012

Prediagnostic plasma vascular endothelial growth factor levels and risk of prostate cancer

artículo científico publicado en 2005

Predicting Outcomes in Prostate Cancer: How Many More Nomograms Do We Need?

article

Predictors of duration of abiraterone acetate in men with castration-resistant prostate cancer.

artículo científico publicado en 2016

Predictors of mortality after prostate-specific antigen failure

artículo científico publicado en 2006

Predictors of prostate cancer tissue acquisition by an undirected core bone marrow biopsy in metastatic castration-resistant prostate cancer--a Cancer and Leukemia Group B study

artículo científico publicado en 2005

Predictors of survival in patients with prostate cancer and spinal metastasis. Presented at the 2009 Joint Spine Section Meeting. Clinical article

artículo científico publicado en 2010

Prevention of Prostate Cancer with Finasteride ⬇️

artículo científico publicado el 16 de octubre de 2003

Prevention, complementary therapies, and new scientific developments in the field of prostate cancer

artículo científico publicado en 2006

Production of glycosylated physiologically "normal" human alpha 1-antitrypsin by mouse fibroblasts modified by insertion of a human alpha 1-antitrypsin cDNA using a retroviral vector

artículo científico publicado en 1987

Prognostic Index Model for Progression-Free Survival in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer Treated With Abiraterone Acetate Plus Prednisone

artículo científico publicado en 2017

Prognostic Significance of Plasma Scatter Factor/Hepatocyte Growth Factor Levels in Patients with Metastatic Hormone- Refractory Prostate Cancer: Results from Cancer and Leukemia Group B 150005/9480

scientific article published on 01 March 2006

Prognostic indicators in hormone refractory prostate cancer

artículo científico publicado en 1999

Prognostic model for predicting survival in men with hormone-refractory metastatic prostate cancer.

artículo científico publicado en 2003

Prognostic significance of baseline reverse transcriptase-PCR for prostate-specific antigen in men with hormone-refractory prostate cancer treated with chemotherapy

artículo científico publicado en 2005

Prognostic significance of detection of prostate-specific antigen transcripts in the peripheral blood of patients with metastatic androgen-independent prostatic carcinoma

artículo científico publicado en 1997

Prognostic significance of plasma chromogranin a levels in patients with hormone-refractory prostate cancer treated in Cancer and Leukemia Group B 9480 study

artículo científico publicado en 2005

Prognostic significance of plasma vascular endothelial growth factor levels in patients with hormone-refractory prostate cancer treated on Cancer and Leukemia Group B 9480.

artículo científico publicado en 2001

Prognostic significance of reverse transcriptase polymerase chain reaction for prostate-specific antigen in men with hormone-refractory prostate cancer

artículo científico publicado en 2001

Prognostic significance of reverse transcriptase polymerase chain reaction for prostate-specific antigen in metastatic prostate cancer: a nested study within CALGB 9583.

artículo científico publicado en 2003

Progressive sclerosis of isolated foot metastasis of prostate cancer

artículo científico publicado en 2002

Prospective Genomic Profiling of Prostate Cancer Across Disease States Reveals Germline and Somatic Alterations That May Affect Clinical Decision Making

artículo científico publicado en 2017

Prospective enterprise-level molecular genotyping of a cohort of cancer patients

artículo científico publicado en 2014

Prospective evaluation of analgesic use and risk of renal cell cancer

artículo científico publicado en 2011

Prospective, multicenter, randomized phase II trial of the herbal supplement, PC-SPES, and diethylstilbestrol in patients with androgen-independent prostate cancer.

artículo científico publicado en 2004

Prospects for gene therapy for immunodeficiency diseases

artículo científico publicado en 1988

Prostate Cancer

Prostate Cancer Risk and ESR1 TA, ESR2 CA Repeat Polymorphisms

artículo científico publicado en 2007

Prostate Cancer, Version 3.2012 Featured Updates to the NCCN Guidelines ⬇️

artículo científico publicado el 1 de septiembre de 2012

Prostate Specific Antigen Working Group guidelines on prostate specific antigen doubling time

artículo científico publicado en 2008

Prostate cancer

scientific article published on 01 January 1993

Prostate cancer 2012: where do we stand and where are we heading?

artículo científico publicado el 1 de diciembre de 2012

Prostate cancer immunotherapy

artículo científico publicado en 2011

Prostate cancer incidence and mortality among men using statins and non-statin lipid-lowering medications

artículo científico publicado en 2019

Prostate cancer, version 1.2014.

artículo científico publicado en 2013

Prostate cancer, version 2.2014

artículo científico publicado en 2014

Prostate cancer. Clinical practice guidelines in oncology

artículo científico publicado en 2007

Prostate intraepithelial neoplasia induced by prostate restricted Akt activation: the MPAKT model

artículo científico publicado en 2003

Prostate-Specific Antigen Failure and Risk of Death Within Comorbidity Subgroups Among Men With Unfavorable-Risk Prostate Cancer Treated in a Randomized Trial

artículo científico publicado en 2016

Prostate-Specific Antigen Screening After 2012 US Preventive Services Task Force Recommendations

artículo científico publicado en 2015

Prostate-specific antigen test for prostate cancer screening: American Society of Clinical Oncology provisional clinical opinion

artículo científico publicado en 2012

Publisher Correction: The long tail of oncogenic drivers in prostate cancer

scientific article published on 01 July 2019

Punctuated evolution of prostate cancer genomes

artículo científico publicado en 2013

Quantum dot-aptamer conjugates for synchronous cancer imaging, therapy, and sensing of drug delivery based on bi-fluorescence resonance energy transfer

artículo científico publicado en 2007

Racial Differences in Genomic Profiling of Prostate Cancer

scientific article published on 01 September 2020

Racial Differences in the Surgical Care of Medicare Beneficiaries With Localized Prostate Cancer.

artículo científico publicado en 2016

Racial differences in screening for prostate cancer in the elderly.

artículo científico publicado en 2004

Racial variation in prostate cancer incidence and in hormonal system markers among male health professionals

artículo científico publicado en 2000

Radiation With or Without Androgen Deprivation Therapy for Localized Prostate Cancer—Reply

artículo científico publicado en 2016

Radiation with or without 6 months of androgen suppression therapy in intermediate- and high-risk clinically localized prostate cancer: a postrandomization analysis by risk group

artículo científico publicado en 2009

Radical prostatectomy lowers plasma vascular endothelial growth factor levels in patients with prostate cancer

artículo científico publicado en 2004

Radiographic progression-free survival as a response biomarker in metastatic castration-resistant prostate cancer: COU-AA-302 results

artículo científico publicado en 2015

Randomized controlled trial of annual zoledronic acid to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer.

artículo científico publicado en 2007

Randomized phase II study of atrasentan alone or in combination with zoledronic acid in men with metastatic prostate cancer

artículo científico publicado en 2006

Randomized, double-blind, placebo-controlled phase III trial comparing docetaxel and prednisone with or without bevacizumab in men with metastatic castration-resistant prostate cancer: CALGB 90401.

artículo científico publicado en 2012

Rapid rise of serum prostate specific antigen levels after discontinuation of the herbal therapy PC-SPES in patients with advanced prostate carcinoma: report of four cases.

artículo científico publicado en 2002

Rate of relapse following treatment for localized prostate cancer: a critical analysis of retrospective reports

artículo científico publicado en 1994

Re: Interdisciplinary Critique of Sipuleucel-T as Immunotherapy in Castration-Resistant Prostate Cancer

artículo científico publicado en 2012

Real-world outcomes of sipuleucel-T treatment in PROCEED, a prospective registry of men with metastatic castration-resistant prostate cancer

scientific article published on 04 September 2019

Recent advances in immunotherapy for the treatment of prostate cancer

artículo científico publicado en 2011

Recent progress in management of advanced prostate cancer

artículo científico publicado en 2005

Recombinant human granulocyte-macrophage colony-stimulating factor as an adjunct to conventional-dose ifosfamide-based chemotherapy for patients with advanced or relapsed germ cell tumors: a randomized trial

scientific article published on 01 January 1995

Regular aspirin use and gene expression profiles in prostate cancer patients

article

Regulation of S100P expression by androgen

artículo científico publicado en 1996

Reply form Authors re: Bertrand Tombal. Continuous Improvement Versus Innovation: The Case for Sipuleucel-T. Eur Urol 2012;61:648–9

article

Reply to L. León et al

Reply to M. Kumar et al

Reply to clinical predictors of survival in men with castration-resistant prostate cancer: evidence that Gleason score 6 cancer can evolve to lethal disease

artículo científico publicado en 2013

Reply to potential underestimation of cerebrovascular events in the PROVENGE registry for the observation, collection, and evaluation of experience data

scientific article published on 10 March 2020

Resistance to docetaxel in prostate cancer is associated with androgen receptor activation and loss of KDM5D expression

scientific journal article

Response to docetaxel/carboplatin-based chemotherapy as first- and second-line therapy in patients with metastatic hormone-refractory prostate cancer

artículo científico publicado en 2008

Response to low-dose ketoconazole and subsequent dose escalation to high-dose ketoconazole in patients with androgen-independent prostate cancer

artículo científico publicado en 2006

Response to second-line chemotherapy in patients with hormone refractory prostate cancer receiving two sequences of mitoxantrone and taxanes

artículo científico publicado en 2006

Restoration of tumor suppression in vivo by systemic delivery of chemically-modified PTEN mRNA nanoparticles.

scientific article published on 06 September 2018

Restoration of tumour-growth suppression in vivo via systemic nanoparticle-mediated delivery of PTEN mRNA

scientific article published on 17 September 2018

Retroperitoneal lymphocele formation after selective laparoscopic retroperitoneal lymph node sampling

artículo científico publicado en 1994

Retroviral Vector-mediated Gene Transfer and Expression in Nonhuman Primates Following Autologous Bone Marrow Transplantation

article

Retroviral-mediated gene transfer into hematopoietic cells.

artículo científico publicado en 1986

Retroviral-mediated gene transfer into hemopoietic cells

artículo científico publicado en 1988

Retroviral-mediated gene transfer into mammalian cells

artículo científico publicado en 1987

Revised Overall Survival Analysis of a Phase II, Randomized, Double-Blind, Controlled Study of PROSTVAC in Men With Metastatic Castration-Resistant Prostate Cancer.

artículo científico publicado en 2016

Ribonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancer

scientific article published on 08 May 2020

Risk of all-cause and prostate cancer-specific mortality after brachytherapy in men with small prostate size

artículo científico publicado en 2010

Risk of prostate cancer recurrence in men treated with radiation alone or in conjunction with combined or less than combined androgen suppression therapy

artículo científico publicado en 2008

Role of Androgen Deprivation Therapy in Early Salvage Radiation Among Patients With Prostate-Specific Antigen Level of 0.5 or Less

scientific article published on 27 June 2014

Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017.

artículo científico publicado en 2017

Role of diet in prostate cancer: the epigenetic link

artículo científico publicado en 2014

Role of microRNA-221/-222 in cancer development and progression.

artículo científico publicado en 2009

Rosiglitazone versus placebo for men with prostate carcinoma and a rising serum prostate-specific antigen level after radical prostatectomy and/or radiation therapy

artículo científico publicado en 2004

SLCO2B1 and SLCO1B3 may determine time to progression for patients receiving androgen deprivation therapy for prostate cancer

artículo científico publicado en 2011

SPINK1 protein expression and prostate cancer progression

artículo científico publicado en 2014

Salvage chemotherapy for testis cancer ⬇️

scholarly article

Screening for Prostate Cancer

artículo científico publicado en 2009

Screening for prostate cancer with prostate-specific antigen testing: American Society of Clinical Oncology Provisional Clinical Opinion

artículo científico publicado en 2012

Secondary Hormonal Therapy in Men With Castration-Resistant Prostate Cancer

article

Selective aromatase inhibition for patients with androgen-independent prostate carcinoma

artículo científico publicado en 2002

Selenium- or Vitamin E-Related Gene Variants, Interaction with Supplementation, and Risk of High-Grade Prostate Cancer in SELECT.

artículo científico publicado en 2016

Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells

artículo científico publicado en 1986

Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.

artículo científico publicado en 2005

Significance of BRCA2 and RB1 Co-loss in Aggressive Prostate Cancer Progression

scientific article published on 03 December 2019

Simultaneous and exact interval estimates for the contrast of two groups based on an extremely high dimensional variable: application to mass spec data

artículo científico publicado en 2007

Single nucleotide polymorphisms and risk of recurrence of renal-cell carcinoma: a cohort study

artículo científico publicado en 2012

Single-nucleotide polymorphisms in p53 pathway and aggressiveness of prostate cancer in a Caucasian population.

artículo científico publicado en 2010

Single-nucleotide polymorphisms within the antioxidant defence system and associations with aggressive prostate cancer

artículo científico publicado en 2011

Sipuleucel-T

scientific article published on 01 July 2010

Sipuleucel-T immune parameters correlate with survival: an analysis of the randomized phase 3 clinical trials in men with castration-resistant prostate cancer

artículo científico publicado en 2012

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

artículo científico publicado en 2010

Smoking and alcohol use may be risk factors for poorer outcome in patients with clear cell renal carcinoma.

artículo científico publicado en 2000

Somatic ERCC2 mutations correlate with cisplatin sensitivity in muscle-invasive urothelial carcinoma

artículo científico publicado en 2014

Statin Use Is Associated with Lower Risk of PTEN-Null and Lethal Prostate Cancer

artículo científico publicado en 2019

Statin Use at the Time of Initiation of Androgen Deprivation Therapy and Time to Progression in Patients With Hormone-Sensitive Prostate Cancer

artículo científico publicado en 2015

Suicidal ideation in prostate cancer survivors: understanding the role of physical and psychological health outcomes.

artículo científico publicado en 2014

Superparamagnetic iron oxide nanoparticle-aptamer bioconjugates for combined prostate cancer imaging and therapy

artículo científico publicado en 2008

Surgical and medical management of germ cell tumors of the chest

artículo científico publicado en 1993

Surrogate End Points for All-Cause Mortality in Men With Localized Unfavorable-Risk Prostate Cancer Treated With Radiation Therapy vs Radiation Therapy Plus Androgen Deprivation Therapy: A Secondary Analysis of a Randomized Clinical Trial

artículo científico

Surrogate endpoints for prostate cancer-specific mortality after radiotherapy and androgen suppression therapy in men with localised or locally advanced prostate cancer: an analysis of two randomised trials

article

Survival Following Radiation and Androgen Suppression Therapy for Prostate Cancer in Healthy Older Men: Implications for Screening Recommendations

artículo científico publicado en 2009

Survival of African-American and Caucasian men after sipuleucel-T immunotherapy: outcomes from the PROCEED registry

scientific article published on 28 February 2020

Symposium on Androgen Action in Prostate Cancer

artículo científico publicado en 2004

Synchronous adenocarcinoma and transitional cell carcinoma of the bladder associated with augmentation: case report and review of the literature

artículo científico publicado en 1993

Synergistic cytotoxicity of irinotecan and cisplatin in dual-drug targeted polymeric nanoparticles

artículo científico publicado en 2012

TMPRSS2 and COVID-19: Serendipity or opportunity for intervention?

scientific article published on 10 April 2020

TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort.

artículo científico publicado en 2007

TREATMENT OF PROSTATE CANCER — HORMONAL THERAPY

Targeted androgen pathway suppression in localized prostate cancer: a pilot study

artículo científico publicado en 2013

Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo

artículo científico publicado en 2006

Testicular cancer. Clinical practice guidelines in oncology

artículo científico publicado en 2006

Testicular cancer. Clinical practice guidelines.

artículo científico publicado en 2005

Testing a multigene signature of prostate cancer death in the Swedish Watchful Waiting Cohort

artículo científico publicado en 2008

The ABC model of prostate cancer: A conceptual framework for the design and interpretation of prognostic studies

artículo científico publicado en 2017

The CAG repeat within the androgen receptor gene and benign prostatic hyperplasia

artículo científico publicado en 1999

The CAG repeat within the androgen receptor gene and its relationship to prostate cancer

artículo científico publicado en 1997

The DHEA-sulfate depot following P450c17 inhibition supports the case for AKR1C3 inhibition in high risk localized and advanced castration resistant prostate cancer

artículo científico publicado en 2014

The Development of Intermediate Clinical Endpoints in Cancer of the Prostate (ICECaP).

artículo científico

The IMAAGEN Study: Effect of Abiraterone Acetate and Prednisone on Prostate-Specific Antigen and Radiographic Disease Progression in Patients with Non-Metastatic Castration-Resistant Prostate Cancer.

artículo científico publicado en 2018

The Ingredients for Prostate Cancer Nomograms: The Addition of Biomarkers Sets the Table for Future Recipes

article

The Role of miRNAs in Prostate Cancer

artículo científico publicado en 2015

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of prostate carcinoma

scientific article published on 20 December 2016

The TMPRSS2:ERG rearrangement, ERG expression, and prostate cancer outcomes: a cohort study and meta-analysis

artículo científico publicado en 2012

The V89L polymorphism in the 5alpha-reductase type 2 gene and risk of prostate cancer

artículo científico publicado en 1999

The altered expression of MiR-221/-222 and MiR-23b/-27b is associated with the development of human castration resistant prostate cancer

artículo científico publicado en 2011

The androgen receptor CAG repeat polymorphism and its relationship to prostate cancer

scientific article published on 01 November 1998

The androgen receptor CAG repeat polymorphism and risk of breast cancer in the Nurses' Health Study

artículo científico publicado en 2002

The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis

artículo científico publicado en 2015

The androgen receptor gene GGN microsatellite and prostate cancer risk ⬇️

artículo científico publicado el 1 de mayo de 1998

The association between germline BRCA2 variants and sensitivity to platinum-based chemotherapy among men with metastatic prostate cancer.

artículo científico publicado en 2017

The effect of prior androgen synthesis inhibition on outcomes of subsequent therapy with docetaxel in patients with metastatic castrate-resistant prostate cancer: results from a retrospective analysis of a randomized phase 3 clinical trial (CALGB 90

artículo científico publicado en 2013

The epidemic of prostate cancer and the medical literature: a causal association?

artículo científico publicado en 1998

The genomic complexity of primary human prostate cancer

artículo científico publicado en 2011

The impact of common genetic variations in genes of the sex hormone metabolic pathways on steroid hormone levels and prostate cancer aggressiveness

artículo científico publicado en 2011

The impact of comorbidity and PSA doubling time on the risk of death in men experiencing PSA failure following radiation therapy with or with androgen deprivation therapy for unfavorable-risk prostate cancer

artículo científico publicado en 2017

The impact of statin use on the efficacy of abiraterone acetate in patients with castration-resistant prostate cancer

artículo científico publicado en 2017

The joint effect of smoking and AIB1 on breast cancer risk in BRCA1 mutation carriers

artículo científico publicado en 2005

The likelihood of death from prostate cancer in men with favorable or unfavorable intermediate-risk disease

artículo científico publicado en 2014

The long tail of oncogenic drivers in prostate cancer.

artículo científico publicado en 2018

The prognostic significance of plasma interleukin-6 levels in patients with metastatic hormone-refractory prostate cancer: results from cancer and leukemia group B 9480.

artículo científico publicado en 2005

The prostate specific antigen. Its use as a tumor marker for prostate cancer.

artículo científico publicado en 1994

The radical prostatectomy series: apples are not oranges

scientific article published on 01 November 1994

The relationship between a polymorphism in CYP17 with plasma hormone levels and prostate cancer

artículo científico publicado en 2001

The role of microRNA-221 and microRNA-222 in androgen-independent prostate cancer cell lines

artículo científico publicado en 2009

The role of sipuleucel-T in therapy for castration-resistant prostate cancer: a critical analysis of the literature

artículo científico

The role of tumor metabolism as a driver of prostate cancer progression and lethal disease: results from a nested case-control study

scientific article published on 07 December 2016

Third international conference on innovations and challenges in prostate cancer: prevention, detection and treatment

artículo científico publicado en 2003

Tight binding inhibitors—IX

artículo científico publicado en 1981

Time course and predictors of symptoms after primary prostate cancer therapy

artículo científico publicado en 2003

Time of metastatic disease presentation and volume of disease are prognostic for metastatic hormone sensitive prostate cancer (mHSPC)

article by Edoardo Francini et al published September 2018 in The Prostate

Time to Prostate-specific Antigen Nadir and the Risk of Death From Prostate Cancer Following Radiation and Androgen Deprivation Therapy

scientific article published on 18 January 2019

Time to disease-related pain and first opioid use in patients with metastatic castration-resistant prostate cancer treated with sipuleucel-T.

artículo científico publicado en 2014

Time to prostate-specific antigen nadir independently predicts overall survival in patients who have metastatic hormone-sensitive prostate cancer treated with androgen-deprivation therapy

artículo científico publicado en 2009

Treatment of Advanced Prostate Cancer

scholarly article by Min Yuen Teo et al published 27 January 2019 in Annual Review of Medicine

Treatment of Metastatic Prostate Cancer in 2018

scientific article published on 01 February 2019

Treatment of locally advanced prostate cancer: is chemotherapy the next step?

artículo científico publicado en 1999

Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3

artículo científico publicado en 2016

Tumor protein expression of the DNA repair gene BRCA1 and lethal prostate cancer

scientific article published on 18 June 2020

Two differentially expressed genes in normal human prostate tissue and in carcinoma

artículo científico publicado en 1996

Update on Systemic Prostate Cancer Therapies: Management of Metastatic Castration-resistant Prostate Cancer in the Era of Precision Oncology

artículo científico publicado en 2018

Uremic levels of oxalic acid suppress replication and migration of human endothelial cells.

artículo científico publicado en 1990

Utilizing predictions of early prostate-specific antigen failure to optimize patient selection for adjuvant systemic therapy trials

scientific article published on 01 September 2000

Vascular endothelial growth factor and basic fibroblast growth factor urine levels as predictors of outcome in hormone-refractory prostate cancer patients: a cancer and leukemia group B study

artículo científico publicado en 2001

Vinorelbine and estramustine in androgen-independent metastatic prostate cancer: a phase II study

artículo científico publicado en 2000

Vitamin D receptor protein expression in tumor tissue and prostate cancer progression

artículo científico publicado en 2011

Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine

artículo científico publicado en 2014

Whole-exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer

artículo científico publicado en 2014

mRNA expression signature of Gleason grade predicts lethal prostate cancer

artículo científico publicado en 2011

p53 protein expression status and recurrence in men treated with radiation and androgen suppression therapy for higher-risk prostate cancer: a prospective phase II Cancer and Leukemia Group B Study (CALGB 9682).

artículo científico publicado en 2008

p63 regulates commitment to the prostate cell lineage

artículo científico publicado en 2005

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda